Results 381 to 390 of about 5,260,709 (398)
Some of the next articles are maybe not open access.
Surgical Clinics of North America, 2008
Ovarian cancer ranks fifth in cancer deaths among women and causes more deaths than any other gynecologic malignancy. It is estimated that 22,430 new cases will be diagnosed and 15,280 deaths will be attributed to ovarian cancer in the United States in 2007.
Nishan, Chobanian, Charles S, Dietrich
openaire +2 more sources
Ovarian cancer ranks fifth in cancer deaths among women and causes more deaths than any other gynecologic malignancy. It is estimated that 22,430 new cases will be diagnosed and 15,280 deaths will be attributed to ovarian cancer in the United States in 2007.
Nishan, Chobanian, Charles S, Dietrich
openaire +2 more sources
Seminars in Oncology Nursing, 1990
Prevention, early detection, morbidity, and survival issues continue to challenge health professionals involved in the care of women with ovarian cancer. While advances in diagnosis, staging, and treatment have been made, survival rates remain grim. Continuing research in the areas of screening, diagnosis, and treatment is the key to improved survival.
J H, Eriksson, J R, Walczak
openaire +2 more sources
Prevention, early detection, morbidity, and survival issues continue to challenge health professionals involved in the care of women with ovarian cancer. While advances in diagnosis, staging, and treatment have been made, survival rates remain grim. Continuing research in the areas of screening, diagnosis, and treatment is the key to improved survival.
J H, Eriksson, J R, Walczak
openaire +2 more sources
Obstetrics & Gynecology, 2001
To examine the symptoms of ovarian cancer in patients compared with symptoms experienced by healthy women using a case-control design.Cases (n = 168) were women with ovarian cancer diagnosed at two hospitals in New York between 1994 and 1997 who were interviewed shortly after diagnosis.
Sara H. Olson +5 more
openaire +3 more sources
To examine the symptoms of ovarian cancer in patients compared with symptoms experienced by healthy women using a case-control design.Cases (n = 168) were women with ovarian cancer diagnosed at two hospitals in New York between 1994 and 1997 who were interviewed shortly after diagnosis.
Sara H. Olson +5 more
openaire +3 more sources
Radiologic Clinics of North America, 2007
Imaging has become an essential part of the clinical management of patients with ovarian cancer, contributing to tumor detection, characterization, staging, treatment planning, and follow-up. Imaging findings incorporated into the clinical impression assist in creating a treatment plan specific for an individual patient.
Svetlana, Mironov +3 more
openaire +2 more sources
Imaging has become an essential part of the clinical management of patients with ovarian cancer, contributing to tumor detection, characterization, staging, treatment planning, and follow-up. Imaging findings incorporated into the clinical impression assist in creating a treatment plan specific for an individual patient.
Svetlana, Mironov +3 more
openaire +2 more sources
Clinical and translational advances in ovarian cancer therapy
Nature Cancer, 2023P. Konstantinopoulos, U. Matulonis
semanticscholar +1 more source
Nursing
Abstract: Ovarian cancer, a leading cause of cancer deaths, poses challenges due to insidious development and vague signs and symptoms. Risk factors include age, reproductive history, genetic mutations, and environmental factors. Treatment involves surgery, chemotherapy, and targeted therapy, with nursing interventions focusing on symptom ...
openaire +4 more sources
Abstract: Ovarian cancer, a leading cause of cancer deaths, poses challenges due to insidious development and vague signs and symptoms. Risk factors include age, reproductive history, genetic mutations, and environmental factors. Treatment involves surgery, chemotherapy, and targeted therapy, with nursing interventions focusing on symptom ...
openaire +4 more sources
Journal of Reproductive Immunology, 1998
Previous observations from our laboratory have demonstrated that the levels of immunoreactive inhibin (ir-inh) are elevated in almost all patients with granulosa cell tumors and in the majority of postmenopausal women with mucinous ovarian cancers.
David Robertson +13 more
openaire +4 more sources
Previous observations from our laboratory have demonstrated that the levels of immunoreactive inhibin (ir-inh) are elevated in almost all patients with granulosa cell tumors and in the majority of postmenopausal women with mucinous ovarian cancers.
David Robertson +13 more
openaire +4 more sources
Seminars in Oncology, 2001
Newer agents and combinations are needed in order to improve current results in the treatment of ovarian cancer. Gemcitabine (Gemzar; Eli Lilly and Company, Indianapolis, IN) is a novel agent with a unique mechanism of action that has shown consistent activity as a single-agent in platinum-resistant ovarian cancer, with remission rates of nearly 20 ...
Mariano Mandachain, Mauro Orlando
openaire +2 more sources
Newer agents and combinations are needed in order to improve current results in the treatment of ovarian cancer. Gemcitabine (Gemzar; Eli Lilly and Company, Indianapolis, IN) is a novel agent with a unique mechanism of action that has shown consistent activity as a single-agent in platinum-resistant ovarian cancer, with remission rates of nearly 20 ...
Mariano Mandachain, Mauro Orlando
openaire +2 more sources
Ovarian Cysts and Ovarian Cancer
InnovAiT: Education and inspiration for general practice, 2009Ovarian cysts and tumours are a relatively common finding among women of many ages, particularly with the wider use of regular physical examinations and ultrasound. Although the finding of an ovarian mass can be a source of considerable anxiety, most of those in younger women are not malignant and may be able to be managed entirely within primary care.
Shiner, Alice, Burbos, Nikolaos
openaire +3 more sources
Seminars in Oncology Nursing, 2002
To review the progress in the management of ovarian cancer in the last decade and future directions.Research studies, review articles, and abstracts.There is an increased understanding of ovarian cancer biology, the genetic basis for hereditary ovarian cancer, staging and the role of cytoreductive surgery, and more effective chemotherapy, resulting in ...
openaire +2 more sources
To review the progress in the management of ovarian cancer in the last decade and future directions.Research studies, review articles, and abstracts.There is an increased understanding of ovarian cancer biology, the genetic basis for hereditary ovarian cancer, staging and the role of cytoreductive surgery, and more effective chemotherapy, resulting in ...
openaire +2 more sources